Although Li et al.'s study reported that the downregulated expression of CLDN7 was correlated with the progression and poor prognosis in CCRCC [44], the relationships between CLDN7, GNAS, and the prognosis of ChRCC were firstly reported in our study. Here, CLDN7 is linked to nonpapillary renal cell carcinoma.